Lateral ventricle injection of orexin-A ameliorates central precocious puberty in rat via inhibiting the expression of MEG3

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 10, 2015, Pages 12564-12570

  Tao, Yue Hong ^a   Sharif, Nazir ^a   Zeng, Bi He ^a   Cai, Yan Yan ^a   Guo, Yu Xiu ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

Central precocious puberty; Hypothalamic pituitary gonadal (HPG) axis; Kisspeptin; MEG3; Orexin A

Indexed keywords

KISS1 PROTEIN, RAT; KISSPEPTIN; LONG UNTRANSLATED RNA; OREXIN;

ANIMAL; BIOSYNTHESIS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETIC TRANSFECTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LATERAL BRAIN VENTRICLE; MOUSE; PHYSIOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEXUAL MATURATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAVENTRICULAR; KISSPEPTINS; LATERAL VENTRICLES; MICE; OREXINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; SEXUAL MATURATION; TRANSFECTION;

EID: 84988631376     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chen M and Eugster EA. Central Precocious Puberty: Update on Diagnosis and Treatment. Paediatric Drugs 2015; 17: 273-81.
2. Zhao L and Zhong Y. Effects of central precocious puberty on physical and sexual development in children. Zhongguo Dang Dai Er Ke Za Zhi 2014; 16: 555-559.
3. Rosati S, Maarouf R, Brown K, Poppe M, Parrish D, Haynes J, Lanning D. Histrelin for central precocious puberty-a single surgeon experience. J Surg Res 2015; 198: 355-9.
4. Silveyra P, Cataldi NI, Lux-Lantos VA, Libertun C. Role of orexins in the hypothalamic-pituitary-ovarian relationships. Acta Physiol (Oxf) 2010; 198: 355-60.
5. Hoyer D and LH Jacobson LH. Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand? Neuropeptides 2013; 47: 477-488.
6. López M, Tenasempere M and Diéguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010; 31: 113-127.
7. Campbell RE, Grove KL and Ms S. Gonadotropin-releasing hormone neurons coexpress orexin 1 receptor immunoreactivity and receive direct contacts by orexin fibers. Endocrinology 2003; 144: 1542-1548.
8. Luk AC, Gao H, Xiao S, Liao J, Wang D, Tu J, Rennert OM, Chan WY, Lee TL. GermlncRNA: a unique catalogue of long non-coding RNAs and associated regulations in male germ cell development. Database (Oxford) 2015; 2015: bav044.
9. Zhou Y, Zhang X and Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Molecular Endocrinol 2012; 48: R45-53.
10. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003; 88: 5119-5126.
11. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008; 93: 4119-25.
12. Zhang X, Zhou Y and Klibanski A. Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach. Molecul Cell Endocrinol 2010; 326: 40-47.
13. Rhie YJ, Lee KH, Ko JM, Lee WJ, Kim JH, Kim HS. KISS1 gene polymorphisms in Korean girls with central precocious puberty. J Korean Med Sci 2014; 29: 1120-5.
14. Kim EY. Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty. Korean J Pediatr 2015; 58: 1-7.
15. Russell SH, Small CJ, Kennedy AR, Stanley SA, Seth A, Murphy KG, Taheri S, Ghatei MA, Bloom SR. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 2001; 142: 5294-5302.
16. Chen CY, Chou YY, Wu YM, Lin CC, Lin SJ, Lee CC. Phthalates may promote female puberty by increasing kisspeptin activity. Hum Reprod 2013; 28: 2765-2773.
17. Navarro VM, Castellano JM, García-Galiano D, Tena-Sempere M. Neuroendocrine factors in the initiation of puberty: the emergent role of kisspeptin. Rev Endocr Metab Disord 2007; 8: 11-20.
18. Rhie YJ, Lee KH, Eun SH, Choi BM, Chae HW, Kwon AR, Lee WJ, Kim JH, Kim HS. Serum kisspeptin levels in Korean girls with central precocious puberty. J Korean Med Sci 2011; 26: 927-931.
19. Sanchez-Garrido MA and Tena-Sempere M. Metabolic control of puberty: roles of leptin and kisspeptins. Horm Behav 2013; 64: 187-194.
20. Pineda R, Garcia-Galiano D, Roseweir A, Romero M, Sanchez-Garrido MA, Ruiz-Pino F, Morgan K, Pinilla L, Millar RP, Tena-Sempere M. Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 2010; 151: 722-730.
21. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007; 282: 24731-24742.